HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phospholipase B levels in fecal pellets from mice infected with Trichinella spiralis, Hymenolepis nana, and Schistosoma mansoni.

Abstract
Fecal pellets of mice infected with Trichinella spiralis, Hymenolepis nana, and Schistosoma mansoni have been found to contain high levels of phospholipase B activity. The rise, time course and decline of the enzymatic content of the pellets correlate with the known patterns of intestinal injury and reaction due to the parasites or their eggs. Treatment with drugs (thiabendazole, niclosamide, niridazole) which are effective in suppressing the infection also prevents the rise, or causes an early decline, in the titers of phospholipase B appearing in the excreta. These findings complement the previous reports of a close correlation between accumulation of this enzyme in the intestine and infection of mice with T. spiralis and H. nana. Determination of fecal phospholipase B activity constitutes a relatively simple, quantitative, and blood-free method of following the course of infection and its response to treatment, which might be of particular advantage in long term studies and preliminary therapeutic screening.
AuthorsA Ottolenghi, J E Larsh Jr, N F Weatherly
JournalThe American journal of tropical medicine and hygiene (Am J Trop Med Hyg) Vol. 29 Issue 3 Pg. 393-400 (May 1980) ISSN: 0002-9637 [Print] United States
PMID7386719 (Publication Type: Journal Article)
Chemical References
  • Niclosamide
  • Phospholipases
  • Lysophospholipase
  • Niridazole
  • Thiabendazole
Topics
  • Animals
  • Feces (enzymology)
  • Hymenolepiasis (drug therapy, enzymology)
  • Lysophospholipase (metabolism)
  • Male
  • Mice
  • Niclosamide (therapeutic use)
  • Niridazole (therapeutic use)
  • Phospholipases (metabolism)
  • Schistosoma mansoni
  • Schistosomiasis (drug therapy, enzymology)
  • Thiabendazole (therapeutic use)
  • Trichinellosis (drug therapy, enzymology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: